$NRX Pharmaceuticals (NRXP.US)$ Prof Jonathan Javitt, MD, MP...

$NRX Pharmaceuticals(NRXP.US)$ Prof Jonathan Javitt, MD, MPH, Chairman and CEO of NRx Pharmaceuticals. "Although, for obvious reasons, our initial focus has been the use of VIP in lung disease caused by COVID-19, we are now considering potential use of ZYESAMI in non COVID-related lung disease, liver disease, eye disease, and organ transplantation.